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Abstract
Raf Kinase Inhibitory Protein (RKIP) is an evolutionarily conserved protein that functions as a
modulator of signaling by the MAP kinase cascade. Implicated as a metastasis suppressor, Raf Kinase
Inhibitory Protein depletion correlates with poor prognosis for breast, prostate and melanoma
tumors but the mechanism is unknown. Recent evidence indicates that Raf Kinase Inhibitory
Protein regulates the mitotic spindle assembly checkpoint by controlling Aurora B Kinase activity,
and the mechanism involves Raf/MEK/ERK signaling. In contrast to elevated MAP kinase signaling
during the G1, S or G2 phases of the cell cycle that activates checkpoints and induces arrest or
senescence, loss of RKIP during M phase leads to bypass of the spindle assembly checkpoint and
the generation of chromosomal abnormalities. These results reveal a role for Raf Kinase Inhibitory
Protein and the MAP kinase cascade in ensuring the fidelity of chromosome segregation prior to
cell division. Furthermore, these data highlight the need for precise titration of the MAP kinase
signal to ensure the integrity of the spindle assembly process and provide a mechanism for
generating genomic instability in tumors. Finally, these results raise the possibility that RKIP status
in tumors could influence the efficacy of treatments such as poisons that stimulate the Aurora B-
dependent spindle assembly checkpoint.
Background
Signaling cascades, the means by which cells translate
external stimuli into discrete physiological endpoints
such as cell growth, must ensure high fidelity and specifi-
city in order to maintain cellular integrity. One of the key
steps regulating cell cycle progression occurs during mito-
sis when proper kinetochore attachment to chromosomes
enables equal and ordered separation of chromosomal
DNA to daughter cells. This process, regulated by the spin-
dle assembly checkpoint, is under exquisite control to
ensure that the cell corrects mistakes prior to cell cycle exit
and cell division. Many of the key regulators of this check-
point have been identified including DNA attachment
proteins, kinesins that drive dynamic changes, checkpoint
proteins that arrest the cycle, and proteins involved in pro-
teosome activity that drive the process forward. Loss of
any of these proteins is deleterious to the progression of
the cell cycle and leads to catastrophic consequences if not
corrected.
One of the mechanisms by which the cell ensures signal-
ing fidelity involves modulators of signaling cascades
such as scaffold proteins that potentiate or inhibit the out-
put. Depletion of these proteins would not compromise
the cell acutely but could lead to slow accumulation of
chromosomal abnormalities culminating in mutation
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and disease. One such modulator, Raf Kinase Inhibitory
Protein (RKIP), was recently shown to function via MAP
kinase as a regulator of the spindle assembly checkpoint
[1].
RKIP, also termed phosphatidylethanonolamine binding
protein (PEBP), is an evolutionarily conserved protein
that regulates growth and differentiation in a variety of
species [2,3]. In mammalian cells, RKIP functions as an
inhibitor of the MAP kinase signaling module comprised
of Raf-1/MEK/ERK1,2 [4]. RKIP inhibits Raf-1 activation
by preventing phosphorylation of key regulatory sites on
Raf-1 [5]. Upon growth factor stimulation of cells, RKIP is
phosphorylated at S153 by protein kinase C (PKC) caus-
ing its dissociation from Raf-1[6]. The released, phospho-
rylated RKIP binds and inhibits GRK2, potentiating G
protein-coupled receptor (GPCR) signaling [7]. Thus,
RKIP functions as an environmental sensor or "switch"
that flips from down regulating the amplitude and dose
response of Raf-1-mediated ERK activation and resultant
DNA synthesis to ameliorating GPCR down regulation
[2,5].
As a regulator of MAP kinase signaling, RKIP has been
implicated in cancer progression. RKIP expression is
reduced in prostate, melanoma and breast cancer, and this
decrease correlates with the extent of metastatic disease
[8,9]. In a xenograft mouse model for prostate cancer,
exogenous RKIP expression suppresses invasion and
metastasis, and this reduction correlates with Raf-1 inhibi-
tion [10]. RKIP also potentiates apoptosis induced by
chemotherapeutic agents, and this has been attributed in
part to its reported inhibition of TNF-α-activated IKKβ in
the NFkB cell survival pathway [11,12]. Since RKIP sup-
presses metastatic progression in a variety of cancers, it is
likely that RKIP affects a fundamental step in the process
rather than targeting tumor-specific mechanisms of inva-
sion or colonization.
Discussion
Recently, a new role for RKIP as a regulator of mitotic pro-
gression during the cell cycle was reported [1]. Initially,
the phosphorylated form of RKIP (pS153) indicative of
Raf-1 activation was detected in association with centro-
somes and prophase/prometaphase kinetochores in a
number of cells and tissues including prostate cancer cells,
brain hippocampus, and head and neck tumor tissues.
Analysis of several rat and human cell types including
HeLa and rat H19-7 hippocampal cells revealed a decrease
in mitotic index upon RKIP depletion and, specifically, of
cells in metaphase. Cell growth rates and apoptotic rates
were unaffected, but a decrease in the time of mitotic
traversal from nuclear envelope breakdown to anaphase
accounted for the observed phenotype. Furthermore,
RKIP-depleted cells overrode the spindle checkpoint trig-
gered by loss of spindle tension after Taxol but not acute
nocodazole treatment, resulting in an increase in Taxol-
induced chromosomal defects.
These phenotypes, including the bypass of the spindle
checkpoint, result from the regulation of Aurora B kinase
by RKIP. Aurora B [13] is an evolutionarily conserved
kinase that has been implicated in chromosomal align-
ment, cytokinesis, and spindle checkpoints. In complex
with other "chromosomal passenger" proteins, Aurora B
accumulates at inner centromeres during prometaphase
and controls the interactions of microtubules with kineto-
chores. The spindle checkpoint delays chromosome segre-
gation in response to problems with spindle attachment
or tension at the kinetochores [14]. This checkpoint is not
only triggered by spindle damage but also plays a role in
the initiation of anaphase in every cell. Aurora B kinase
specifically regulates activation of the spindle checkpoint
in response to loss of tension due to poisons such as
Taxol, [15,16]. A decrease in Aurora B localization and
kinase activity at the kinetochore alters the integrity of the
spindle assembly checkpoint, the same phenotype
observed in RKIP-depleted cells exposed to Taxol. Consist-
ent with this observation, RKIP depletion causes inhibi-
tion of Aurora B kinase activity and decreased detection of
phosphorylated Aurora B and its substrate CENP-A at
kinetochores.
The mitotic defects elicited by RKIP depletion were due, at
least in part, to elevated MAP kinase activity. Activated
Raf-1 was localized on early mitotic kinetochores, activa-
tion of the MAP kinase cascade mimicked effects of RKIP
depletion, and inhibition of ERK1,2 signaling by either
drugs, dominant-negative MEK, or siRNA for Raf-1 res-
cued defects caused by RKIP loss. The specific mitotic tar-
get of MAP kinase action has not yet been identified. The
passenger protein complex consisting of Aurora B,
INCENP, Survivin and Borealin/Dasra B is required for
maintaining the integrity of mitotic regulation, including
phosphorylation of histone H3 and its variant CENP-A,
spindle assembly, chromatin-induced stabilization of
microtubules, and mitotic arrest in response to microtu-
bule poisons such as Taxol [17]. The passenger proteins
stabilize Aurora B localization to the inner centromere
and are required for kinetochore-associated Aurora B
kinase activity. Although Aurora B is not a direct substrate
of MAP kinase, it is possible that MAP kinase regulates the
translocation of Aurora B to kinetochores or Aurora B
kinase activity by phosphorylation of the passenger pro-
teins. Taken together, the results of this study[1] demon-
strate that loss of RKIP, through hyperactivation of the
Raf/MEK/ERK1,2 signaling cascade, regulates the mitotic
checkpoint via inhibition of Aurora B kinase.Cell Division 2007, 2:1 http://www.celldiv.com/content/2/1/1
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The Raf/MAPK signaling cascade has been implicated pre-
viously in regulation of cell cycle checkpoints during G1,
S and G2. However, the role of the MAPK pathway during
the G2/M phase of the mammalian mitotic cell cycle has
been a subject of considerable controversy. Several studies
have shown that excessive activation of Raf and MAP
kinase in G1 leads to upregulation of cyclin-dependent
kinase inhibitors, culminating in cell arrest or senescence
[18,19]. Depletion of the dual-specific tyrosine phos-
phatase VHR upregulates p21 and causes arrest or senes-
cence at the G1-S and G2-M stages of the cell cycle [20].
VHR down regulates both ERK1,2 and JNK, and inhibi-
tion of both of these MAP kinase subfamilies partially res-
cues the cell arrest phenotype. Raf-1-activated MEK1 and
ERK1c, an ERK variant, promote mitotic Golgi fragmenta-
tion and G2 progression [21,22]. Oncogenic H-Ras
expression in thyroid cells leads to bypass of the G2 DNA
damage checkpoint in a MEK/ERK-dependent manner,
but activation of the B-Raf pathway alone is insufficient
for the checkpoint override [23]. Very recently, Shapiro
and coworkers showed that cells synchronized at the G1-
S boundary and then stimulated by EGF or TPA induce
p21 and transient arrest at the G2-M boundary in a MEK/
ERK-dependent fashion [24]. The apparent contradictory
ability of ERK to promote G2/M arrest but also potentiate
bypass of the G2 checkpoint presumably reflects differ-
ences in stimuli and cell type. Although more work needs
to be done to sort out the specific role of MAP kinase in
G2, these results indicate that the Raf/MEK/ERK cascade
plays a key regulatory role in the G1-S and G2-M stages of
the cell cycle. Given that RKIP influences the amplitude of
ERK signaling, it is likely that RKIP may play a regulatory
role in the G1-S and G2 stages of the cell cycle as well as
in mitosis.
How does this new finding about RKIP regulation of the
spindle checkpoint relate to our understanding of MAPK
and mitosis? Although many of the fundamental players
in mitotic regulation of eukaryotes were discovered using
Xenopus eggs as a model system, the function of MAPK in
this system is distinct from that in mammalian cells. In
Xenopus egg extracts, MAPK is not required for mitotic
entry or exit, and MAPK activation promotes cell cycle
arrest [25,26]. By contrast, in mammalian cells, the Raf-1/
ERK1,2 cascade may influence entry into mitosis and
functions to bypass spindle checkpoint arrest [1,27,28].
Acute activation of either B-Raf or the Raf kinase domain
during G2 leads to a decrease in the mitotic index and at
least partial override of the spindle checkpoint [1,23].
Consistent with this role at the metaphase/anaphase
boundary, active Raf-1 and ERK1,2 are associated with
kinetochores, and active ERK has been localized to spin-
dle poles from prometaphase to anaphase and with the
midbody at later stages of mitosis [1,29,30]. However, it
is possible that RKIP and ERK target an earlier step in the
mitotic process. As a regulator of the spindle checkpoint,
RKIP functions as a negative modulator that controls the
amplitude and dose response of Raf-1 kinase activity
rather than the absolute on or off state. Interestingly,
excessive MAP kinase activity drives cell arrest or senes-
cence at the G1-S and G2-M boundaries, but causes cells
to bypass the spindle checkpoint in the absence of normal
RKIP expression.
Conclusion
The regulation of the mitotic spindle checkpoint by RKIP
provides a potential explanation for some of its growth
and tumor-regulating functions. Treatment of cells with
chemotherapeutic agents such as Taxol can enhance RKIP
expression in the arrested cells [11]. These results suggest
that this enhancement may be caused to some extent by
the normal increase in RKIP expression that occurs during
mitosis. Similarly, it has been shown that RKIP can poten-
tiate the extent of apoptotic death induced by chemother-
apy [11]. If RKIP promotes arrest or apoptosis due to the
mitotic checkpoint, then higher levels of RKIP should
increase cell death. Conversely, depletion of RKIP should
lead to slippage of cells through the checkpoint resulting
in fewer arrested or apoptotic cells and an increase in ane-
uploidy depending upon the specific cell type. In fact,
expression of oncogenic Ras, an upstream activator of Raf-
1, has been shown to promote chromosome instability
via ERK [31]. The possibility that RKIP depletion pro-
motes genomic instability, similar to spindle checkpoint
proteins, needs to be tested directly in a mouse model.
Partial suppression of the spindle checkpoint rather than
its total elimination is more likely to lead to cancer given
that complete inactivation could result in cell death [14].
RKIP depletion causes a partial suppression of the spindle
checkpoint in cells exposed to low levels of Taxol. Higher
Taxol levels induce dramatic chromosomal abnormalities
and eventually catastrophic cell death. Interestingly, RKIP
itself does not trigger cell death unless overexpressed or
mutated to block dissociation from Raf-1. Conversely,
loss of endogenous RKIP or enhanced Raf kinase activa-
tion induces a spindle checkpoint defect that enables cells
to escape Taxol-induced arrest more easily. Cells either
proceed through division or die dependent on the dose,
suggesting that RKIP levels in cancer cells can influence
the Taxol regimen needed for toxicity. These data indicate
that Raf-1 kinase activity must be tightly regulated during
mitosis, and RKIP plays a key role in modulating this
activity. Cells lacking RKIP should display an increase in
chromosomal abnormalities and genetic changes when
under oncogenic or toxic stress. Future therapeutic strate-
gies for cancer treatment should be able to take advantage
of the RKIP status of tumor cells in order to selectively
potentiate cell death.Cell Division 2007, 2:1 http://www.celldiv.com/content/2/1/1
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